Drug Shortage Report for CISATRACURIUM OMEGA MULTIDOSE

Last updated on 2021-08-04 History
Report ID 131360
Drug Identification Number 02408813
Brand name CISATRACURIUM OMEGA MULTIDOSE
Common or Proper name Cisatracurium Besylate Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) CISATRACURIUM
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 10mL vial / fiole
ATC code M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-01-05
Actual start date
Estimated end date Unknown
Actual end date 2021-08-03
Shortage status Resolved
Updated date 2021-08-04
Company comments Covid. On Allocation at 100%
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-08-04 French Compare
v7 2021-08-04 English Compare
v6 2021-06-03 French Compare
v5 2021-06-03 English Compare
v4 2021-03-24 French Compare
v3 2021-03-24 English Compare
v2 2021-01-11 French Compare
v1 2021-01-11 English Compare

Showing 1 to 8 of 8